Our Mission to Transform Treatment Outcomes in Cancer | Genomic Health, Inc.
World’s Leading Provider of Genomic-Based Tests for Personalising Cancer Care
Our Mission: To transform treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services for patients.
Our Vision: To revolutionise the treatment of cancer throughout the patient journey.
Genomic Health UK, Ltd., located in London, is part of the global company Genomic Health, a world-leading provider of genomic-based diagnostic tests that inform treatment decisions and help to ensure each patient receives appropriate treatment for early stage cancer. The company is applying its state-of-the-art scientific and commercial expertise and infrastructure to translate significant amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey; from diagnosis to treatment selection and monitoring.
Genomic Health conducts genomic research to develop clinically-validated molecular diagnostic tests, which provide individualised information about certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare professionals and patients can use to make more efficient treatment decisions.
Learn more about Genomic Health
Read personal insights from our executives.
See what’s behind our tests which are improving treatment decisions and providing significant benefit from both a care and cost perspective.
Our World Class Commercial Channel
We deliver over 400 Oncotype DX test results per day to more than 90 countries through our centralised clinical laboratory.